Safety and efficacy of sintilimab combined with oxaliplatin/capecitabine as first-line treatment in patients with locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in a phase Ib clinical trial

Peer Review reports

Original Submission
24 Mar 2020	Submitted	Original manuscript
17 Apr 2020	Reviewed	Reviewer Report
24 Apr 2020	Reviewed	Reviewer Report
21 May 2020	Author responded	Author comments - Haiping Jiang
Resubmission - Version 2
21 May 2020	Submitted	Manuscript version 2
24 May 2020	Reviewed	Reviewer Report
28 May 2020	Reviewed	Reviewer Report
9 Jun 2020	Author responded	Author comments - Haiping Jiang
Resubmission - Version 3
9 Jun 2020	Submitted	Manuscript version 3
10 Jun 2020	Reviewed	Reviewer Report
16 Jun 2020	Author responded	Author comments - Haiping Jiang
Resubmission - Version 4
16 Jun 2020	Submitted	Manuscript version 4
Publishing
3 Aug 2020	Editorially accepted
14 Aug 2020	Article published	10.1186/s12885-020-07251-z

Back to article page